Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma

被引:31
作者
Liao, Qiulin [2 ,3 ]
Zhao, Liang [1 ,2 ,3 ]
Chen, Xiaodong [4 ]
Deng, Yongjian [1 ,2 ]
Ding, Yanqing [1 ,2 ,3 ]
机构
[1] So Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou 510515, Peoples R China
[2] So Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Peoples R China
[3] So Med Univ, Key Lab Funct Prote & Mol Tumor Pathol Guangdong, Guangzhou 510515, Peoples R China
[4] Gen Hosp Guangzhou Mil Command, Dept Pathol, Guangzhou, Peoples R China
关键词
nasopharyngeal carcinoma; serum proteome; carcinogenesis; lymph node metastasis;
D O I
10.1007/s10585-008-9152-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC), one of the most common cancers in population with Chinese or Asian progeny, poses a serious health problem for southern China. It is unfortunate that most NPC victims have had lymph node metastasis (LNM) when first diagnosed. We believe that the 2D based serum proteome analysis can be useful in discovering new biomarkers that may aid in the diagnosis and therapy of NPC patients. To filter the tumor specific antigen markers of NPC, sera from 42 healthy volunteers, 27 non-LNM NPC patients and 37 LNM NPC patients were selected for screening study using 2D combined with MS. Pretreatment strategy, including sonication, albumin and immunoglobulin G (IgG) depletion, was adopted for screening differentially expressed proteins of low abundance in serum. By 2D image analysis and MALDI-TOF-MS identification, twenty-three protein spots were differentially expressed. Three of them were further validated in the sera using enzyme-linked immunosorbent assay (ELISA). Our research demonstrates that HSP70, sICAM-1 and SAA, confirmed with ELISA at sera and immunohistochemistry, are potential NPC metastasis-specific serum biomarkers which may be of great underlying significance in clinical detection and management of NPC.
引用
收藏
页码:465 / 476
页数:12
相关论文
共 70 条
  • [1] Abe Miyako, 2004, Clin Prostate Cancer, V3, P49, DOI 10.3816/CGC.2004.n.013
  • [2] The human plasma proteome - History, character, and diagnostic prospects
    Anderson, NL
    Anderson, NG
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) : 845 - 867
  • [3] The human plasma proteome - A nonredundant list developed by combination of four separate sources
    Anderson, NL
    Polanski, M
    Pieper, R
    Gatlin, T
    Tirumalai, RS
    Conrads, TP
    Veenstra, TD
    Adkins, JN
    Pounds, JG
    Fagan, R
    Lobley, A
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) : 311 - 326
  • [4] Barnes JA, 2001, CELL STRESS CHAPERON, V6, P316, DOI 10.1379/1466-1268(2001)006<0316:EOIHET>2.0.CO
  • [5] 2
  • [6] RAPID CLEARANCE OF SERUM AMYLOID-A FROM HIGH-DENSITY LIPOPROTEINS
    BAUSSERMAN, LL
    HERBERT, PN
    RODGER, R
    NICOLOSI, RJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 792 (02) : 186 - 191
  • [7] BECKER JC, 1993, J IMMUNOL, V151, P7224
  • [8] SERUM AMYLOID A PROTEIN IN AMYLOIDOSIS, RHEUMATIC, AND NEOPLASTIC DISEASES
    BENSON, MD
    COHEN, AS
    [J]. ARTHRITIS AND RHEUMATISM, 1979, 22 (01): : 36 - 42
  • [9] SERUM AMYLOID-A (SAA) VARIATIONS IN PATIENTS WITH CANCER - CORRELATION WITH DISEASE-ACTIVITY, STAGE, PRIMARY SITE, AND PROGNOSIS
    BIRAN, H
    FRIEDMAN, N
    NEUMANN, L
    PRAS, M
    SHAINKINKESTENBAUM, R
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (07) : 794 - 797
  • [10] Budnik A, 1996, EXP HEMATOL, V24, P352